Bicara Therapeutics Inc. (BCAX)

NASDAQ: BCAX · Real-Time Price · USD

21.56

-0.13 (-0.60%)

At close: Jun 15, 2026, 4:00 PM EDT

21.99

+0.43 (1.99%)

After-hours: Jun 15, 2026, 5:58 PM EDT

Bicara Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Cap	1,417	953	948	-	-
Market Cap Growth	175.16%	0.45%	-	-	-
Enterprise Value	878.26	539.5	459.37	0	0
Last Close Price	21.56	16.83	17.42	-	-
PB Ratio	2.75	2.37	1.93	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0
Net Debt / Equity Ratio	-1.05	-1.03	-0.99	1.55	0.04
Net Debt / EBITDA Ratio	3.10	2.66	5.94	5.76	0.11
Net Debt / FCF Ratio	4.62	3.86	6.54	4.97	0.13
Quick Ratio	13.72	14.33	27.22	15.28	0.17
Current Ratio	13.85	14.58	27.93	15.32	0.21
Return on Equity (ROE)	-34.37%	-30.88%	-19.14%	-51.67%	219.04%
Return on Assets (ROA)	-35.40%	-33.12%	-22.21%	-33.15%	-561.79%
Return on Invested Capital (ROIC)	-1753.11%	-1719.43%	-1466.91%	-1623.97%	-2190.63%
Return on Capital Employed (ROCE)	-37.99%	-34.81%	-23.18%	-39.55%	219.02%
Buyback Yield / Dilution	-85.90%	-225.35%	-2796.96%	-35.20%	-
Total Shareholder Return	-85.90%	-225.35%	-2796.96%	-35.20%	-

SEC Filings: 10-K · 10-Q